ivy semaglutide Compounded Losing weight and keeping it off can lessen the many health risks that come with obesity Let's talk GLP-1s 💊 ⁠

When switching to tirzepatide might make sense Tirzepatide (brand name Mounjaro/Zepbound) is a dual GIP/GLP-1 receptor agonist that has shown greater weight loss than semaglutide in head-to-head trials

Wegovy is another GLP-1 weight loss drug made by the same company and indicated for weight management

Jawline and Neck If you have a double chin after weight loss, you may have residual fat plus laxity

Most patients should allow at least 12 weeks at the maintenance dose of 2.4 mg weekly before evaluating effectiveness, as clinical trials measured outcomes at 68 weeks

Clinical trials Retatrutide clinical trials Retatrutide is investigational

Patients with certain genetic profiles may experience less bloating naturally, or may benefit from personalized dosing strategies that minimize this side effect from the start